Stockscreener 앱 받기
1.42
2.07%
-0.03
시간 외 거래:
1.43
0.01
+0.70%
전일 마감가:
$1.45
열려 있는:
$1.46
하루 거래량:
285.72K
Relative Volume:
0.40
시가총액:
$58.57M
수익:
$68.68M
순이익/손실:
$-60.84M
주가수익비율:
-0.8875
EPS:
-1.6
순현금흐름:
$-38.42M
1주 성능:
-2.07%
1개월 성능:
-28.64%
6개월 성능:
-10.69%
1년 성능:
-79.74%
1일 변동 폭
$1.39
$1.46
1주일 범위
$1.375
$1.5583
52주 변동 폭
$1.31
$9.37
풀몬스 Stock (LUNG) Company Profile
명칭
Pulmonx Corp
전화
650-364-0400
주소
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.42 | 59.81M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
풀몬스 Stock (LUNG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-31 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | 개시 | D. Boral Capital | Buy |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-04 | 개시 | Lake Street | Buy |
| 2024-02-23 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 개시 | Craig Hallum | Buy |
| 2023-02-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2021-03-25 | 개시 | Piper Sandler | Neutral |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-10-26 | 개시 | BofA Securities | Buy |
| 2020-10-26 | 개시 | Canaccord Genuity | Buy |
| 2020-10-26 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 개시 | Stifel | Buy |
| 2020-10-26 | 개시 | Wells Fargo | Equal Weight |
모두보기
풀몬스 주식(LUNG)의 최신 뉴스
Pulmonx (LUNG) Expected to Announce Earnings on Wednesday - Defense World
Merger Talk: Is Pulmonx Corporation a good ESG investment2025 Key Highlights & Free Community Consensus Stock Picks - baoquankhu1.vn
Pulmonx Aktie: Zahlen im Fokus - Börse Global
Pulmonx Q4 2025 Results: A Litmus Test for New Leadership - AD HOC NEWS
Sentiment Watch: Is Pulmonx Corporation a turnaround story2025 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
US Market Wrap: Can Cabaletta Bio Inc disrupt its industryJuly 2025 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Analyzing Pulmonx (NASDAQ:LUNG) and Privia Health Group (NASDAQ:PRVA) - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Aug Rallies: How Pulmonx Corporation stock compares to growth peersJuly 2025 Gainers & Reliable Volume Spike Alerts - Bộ Nội Vụ
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return - Yahoo Finance
Is Pulmonx Corporation stock vulnerable to regulatory risks2025 Price Targets & Weekly High Potential Alerts - Улправда
How Pulmonx Corporation stock valuations compare to rivalsTrade Performance Summary & AI Driven Stock Price Forecasts - Улправда
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of “Hold” by Brokerages - Defense World
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story - Yahoo Finance
Pulmonx (NASDAQ:LUNG) Trading Up 2.5%Here's What Happened - MarketBeat
EBITDA per share of Pulmonx Corp. – GETTEX:4NI - TradingView — Track All Markets
What technical charts say about Pulmonx Corporation stockWeekly Stock Summary & AI Enhanced Trade Execution Alerts - Улправда
Why Pulmonx Corporation stock is in analyst buy zoneJuly 2025 PreEarnings & AI Driven Stock Reports - Улправда
Can Pulmonx Corporation stock hit analyst price targetsDay Trade & Reliable Price Action Trade Plans - Улправда
How strong is Pulmonx Corporation stock revenue growthQuarterly Trade Report & Short-Term High Return Ideas - Улправда
Can Pulmonx Corporation stock resist sector downturnsJuly 2025 Drop Watch & Breakout Confirmation Alerts - Улправда
Will Pulmonx Corporation stock deliver better than expected guidanceJuly 2025 Closing Moves & Community Trade Idea Sharing - Улправда
How Pulmonx Corporation stock performs in interest rate cyclesJuly 2025 Patterns & High Conviction Investment Ideas - Улправда
Will Pulmonx Corporation stock continue upward momentumJuly 2025 Opening Moves & Stepwise Trade Signal Guides - Улправда
Pulmonx Navigates Leadership Shift Amidst Mixed Financial Results - AD HOC NEWS
What New Catalysts Are Shifting the Pulmonx Story for Investors - Yahoo Finance
Comparing Careview Communications (OTCMKTS:CRVW) and Pulmonx (NASDAQ:LUNG) - Defense World
Insider Selling: Daniel Florin Sells Shares of Pulmonx Corp (LUN - GuruFocus
Pulmonx Corp Director Daniel P Florin Sells 23,321 Shares - TradingView — Track All Markets
Check out these key findings about Pulmonx Corp (LUNG) - setenews.com
Dir Florin Files To Sell 23,321 Of Pulmonx Corp [LUNG] - TradingView — Track All Markets
Pulmonx (LUNG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Improved Revenues Required Before Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Jump Looks Justified - simplywall.st
Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock - MarketBeat
Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares - MarketBeat
Pulmonx CEO French sells $13.8k in LUNG stock By Investing.com - Investing.com Australia
Pulmonx CEO French sells $13.8k in LUNG stock - Investing.com India
Pulmonx Corp General Counsel Sells Shares to Cover Tax Obligations - TradingView
LUNG FinancialsIncome Statement - Quiver Quantitative
Pulmonx Corporation Grants 1,625,000 Equity Awards as Part of 2025 Inducement Plan - Quiver Quantitative
Pulmonx (Nasdaq: LUNG) issues 1,625,000-share inducement grants, incl. 1.6M RSUs/PSUs - Stock Titan
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of “Hold” by Brokerages - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Check Out Pulmonx Corp (LUNG)’s Trade Data Rather Than the Analysts’ Views - Setenews
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
[S-3/A] Pulmonx Corp Amended Shelf Registration Statement | LUNG SEC FilingForm S-3/A - Stock Titan
[S-8] Pulmonx Corp Employee Benefit Plan Registration | LUNG SEC FilingForm S-8 - Stock Titan
Holdings of Pulmonx Corp (LUNG) are aligned with the stars - setenews.com
Pulmonx Corporation (LUNG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Technical signs of recovery in Pulmonx CorporationQuarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com
풀몬스 (LUNG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.31%
자본화:
|
볼륨(24시간):